Lucid Diagnostics Inc.
NASDAQ:LUCD
Overview | Financials
Company Name | Lucid Diagnostics Inc. |
Symbol | LUCD |
Currency | USD |
Price | 0.775 |
Market Cap | 45,996,356 |
Dividend Yield | 0% |
52-week-range | 0.63 - 1.58 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Lishan Aklog M.D. |
Website | https://www.luciddx.com |
An error occurred while fetching data.
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD